Trial intelligence / Profile preview

Risperdal CONSTA in first-episode psychosis

NCT00314613Phase 4Terminated

Sponsor
Duke University
Start
Apr 2006
Primary completion
Dec 2006
Countries
1
01

Overview

A Phase 4 trial of risperidone in schizophrenia, schizoaffective disorder, schizophreniform disorder, sponsored by Duke University. Started Apr 2006; status: terminated.

02

Drugs

risperidone
03

Conditions

schizophreniaschizoaffective disorderschizophreniform disorder

Beyond the preview

Go deeper on NCT00314613.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00314613.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call